The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy
2015 ◽
Vol 172
(10)
◽
pp. 2618-2633
◽
1991 ◽
Vol 9
(4)
◽
pp. 317-339
◽
2002 ◽
Vol 25
(7)
◽
pp. 857-860
◽
2004 ◽
Vol 2
(3)
◽
pp. 492-498
◽
Keyword(s):
2012 ◽
Vol 55
(17)
◽
pp. 7849-7861
◽
Keyword(s):
2010 ◽
Vol 333
(1)
◽
pp. 152-160
◽